Management of Thalamocapsular Infarct in Older Patients

Acute Phase Management

The American Heart Association recommends initiating antiplatelet therapy with aspirin 75-162 mg plus extended-release dipyridamole as first-line treatment for older patients with thalamocapsular infarct and vascular risk factors, with a Class I, Level B recommendation 1
Aggressive control of blood pressure to <130/80 mm Hg is recommended for secondary stroke prevention, with a Class IIb recommendation 1
High-dose statin therapy with atorvastatin 80 mg daily is recommended for secondary prevention, regardless of baseline cholesterol levels, with a Class I, Level B recommendation 1

The American College of Cardiology recommends targeting blood pressure <130/80 mm Hg for secondary stroke prevention, with a Class IIb recommendation 1
The American Diabetes Association recommends treating hypertension in virtually all older adults with atherosclerotic cardiovascular disease 2, 3, 4
ACE inhibitors or angiotensin receptor blockers are preferred agents for blood pressure management, particularly in patients with diabetes or heart failure 6

The American College of Cardiology recommends starting atorvastatin 80 mg daily for secondary prevention, with a Class I, Level B recommendation 1
The American College of Cardiology recommends targeting LDL-cholesterol <100 mg/dL, or <70 mg/dL for very high-risk patients 1
Statin therapy has demonstrated benefit in patients up to the early 80s, with a Grade 2B recommendation 6

The American Diabetes Association recommends optimizing glycemic control while avoiding hypoglycemia, with individualized A1C targets based on functional status and life expectancy 2, 3, 4
The American Diabetes Association recommends targeting A1C <7.5% for healthy older adults, <8.0% for complex/intermediate health status, and <8.5% for very complex/poor health 4

The American Heart Association recommends aggressive treatment of hypertension to improve prognosis in older patients with peripheral artery disease and other atherosclerotic conditions 7
The American Diabetes Association recommends screening for diabetes complications, with particular attention to complications that would lead to functional impairment 2, 3

The American College of Cardiology recommends considering life expectancy, functional status, and the time frame of benefit from interventions when setting treatment goals 8, 2, 4
The American Heart Association notes that older adults with atherosclerotic cardiovascular disease often have multiple risk factors occurring in clusters with substantial comorbidity burden 7